133 related articles for article (PubMed ID: 11348484)
1. Pharmacokinetics and pharmacodynamics of antiulcer agents in llama.
Christensen JM; Limsakun T; Smith BB; Hollingshead N; Huber M
J Vet Pharmacol Ther; 2001 Feb; 24(1):23-33. PubMed ID: 11348484
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of oral omeprazole in llamas.
Poulsen KP; Smith GW; Davis JL; Papich MG
J Vet Pharmacol Ther; 2005 Dec; 28(6):539-43. PubMed ID: 16343286
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Sekar VJ; Lefebvre E; De Paepe E; De Marez T; De Pauw M; Parys W; Hoetelmans RM
Antimicrob Agents Chemother; 2007 Mar; 51(3):958-61. PubMed ID: 17210768
[TBL] [Abstract][Full Text] [Related]
4. Effects of single intravenously administered doses of omeprazole and ranitidine on intragastric pH and plasma gastrin concentration in nonfed ponies.
Baker SJ; Gerring EL
Am J Vet Res; 1993 Dec; 54(12):2068-74. PubMed ID: 8116940
[TBL] [Abstract][Full Text] [Related]
5. Intravenous omeprazole in children: pharmacokinetics and effect on 24-hour intragastric pH.
Faure C; Michaud L; Shaghaghi EK; Popon M; Turck D; Navarro J; Jacqz-Aigrain E
J Pediatr Gastroenterol Nutr; 2001 Aug; 33(2):144-8. PubMed ID: 11568514
[TBL] [Abstract][Full Text] [Related]
6. Suppression of gastric acid with intravenous esomeprazole and omeprazole: results of 3 studies in healthy subjects.
Röhss K; Wilder-Smith C; Kilhamn J; Fjellman M; Lind T
Int J Clin Pharmacol Ther; 2007 Jun; 45(6):345-54. PubMed ID: 17595892
[TBL] [Abstract][Full Text] [Related]
7. Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
Knych HK; Stanley SD; Arthur RM; McKemie DS
J Vet Pharmacol Ther; 2017 Jan; 40(1):92-96. PubMed ID: 27292271
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and pharmacodynamics of ranitidine in critically ill children.
Lugo RA; Harrison AM; Cash J; Sweeley J; Vernon DD
Crit Care Med; 2001 Apr; 29(4):759-64. PubMed ID: 11373465
[TBL] [Abstract][Full Text] [Related]
9. The comparative effects of lansoprazole, omeprazole, and ranitidine in suppressing gastric acid secretion.
Blum RA; Shi H; Karol MD; Greski-Rose PA; Hunt RH
Clin Ther; 1997; 19(5):1013-23. PubMed ID: 9385488
[TBL] [Abstract][Full Text] [Related]
10. A randomized crossover study investigating the influence of ranitidine or omeprazole on the pharmacokinetics of cephalexin monohydrate.
Madaras-Kelly K; Michas P; George M; May MP; Adejare A
J Clin Pharmacol; 2004 Dec; 44(12):1391-7. PubMed ID: 15545310
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats.
Izzettin FV; Sancar M; Okuyan B; Apikoglu-Rabus S; Cevikbas U
Exp Toxicol Pathol; 2012 May; 64(4):339-43. PubMed ID: 21030227
[TBL] [Abstract][Full Text] [Related]
12. Plasma pharmacokinetics of ranitidine HCl in foals.
Holland PS; Brumbaugh GW; Ruoff WW; Brown SA
J Vet Pharmacol Ther; 1997 Dec; 20(6):447-52. PubMed ID: 9430768
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children.
Tran A; Rey E; Pons G; Pariente-Khayat A; D'Athis P; Sallerin V; Dupont C
Clin Pharmacol Ther; 2002 May; 71(5):359-67. PubMed ID: 12011821
[TBL] [Abstract][Full Text] [Related]
14. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
Šutalo S; Ruetten M; Hartnack S; Reusch CE; Kook PH
J Vet Intern Med; 2015; 29(3):840-6. PubMed ID: 25966746
[TBL] [Abstract][Full Text] [Related]
15. The effect of omeprazole on the pharmacokinetics of metronidazole and hydroxymetronidazole in human plasma, saliva and gastric juice.
Jessa MJ; Goddard AF; Barrett DA; Shaw PN; Spiller RC
Br J Clin Pharmacol; 1997 Sep; 44(3):245-53. PubMed ID: 9296318
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole.
Andersson T; Röhss K; Bredberg E; Hassan-Alin M
Aliment Pharmacol Ther; 2001 Oct; 15(10):1563-9. PubMed ID: 11563995
[TBL] [Abstract][Full Text] [Related]
17. A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers.
Schöller-Gyüre M; Kakuda TN; De Smedt G; Vanaken H; Bouche MP; Peeters M; Woodfall B; Hoetelmans RM
Br J Clin Pharmacol; 2008 Oct; 66(4):508-16. PubMed ID: 18492125
[TBL] [Abstract][Full Text] [Related]
18. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome.
Vinayek R; Amantea MA; Maton PN; Frucht H; Gardner JD; Jensen RT
Gastroenterology; 1991 Jul; 101(1):138-47. PubMed ID: 2044903
[TBL] [Abstract][Full Text] [Related]
20. Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
Klein CE; Chiu YL; Cai Y; Beck K; King KR; Causemaker SJ; Doan T; Esslinger HU; Podsadecki TJ; Hanna GJ
J Clin Pharmacol; 2008 May; 48(5):553-62. PubMed ID: 18440920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
